# Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer

> **NCT01790035** · PHASE1 · TERMINATED · sponsor: **Washington University School of Medicine** · enrollment: 23 (actual)

## Conditions studied

- Gastrointestinal Neoplasms

## Interventions

- **DRUG:** LGG
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01790035
- **Lead sponsor:** Washington University School of Medicine
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2014-08-19
- **Primary completion:** 2017-01-12
- **Final completion:** 2021-12-12
- **Target enrollment:** 23 (ACTUAL)
- **Why stopped:** Low accrual
- **Last updated:** 2022-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01790035

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01790035, "Probiotic LGG for Prevention of Side Effects in Patients Undergoing Chemoradiation for Gastrointestinal Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01790035. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*